SADDLE BROOK, N.J.,
Nov. 10, 2011 /PRNewswire/ --
Herborium Group, Inc., (PK: HBRM) www.herborium.com, a Botanical
Therapeutics™ company, announced today that it has retained the
services of Extreme Media, a public relations firm specializing in
Social Media, to launch the Company's social media marketing
campaign for its proprietary acne treatment AcnEase®. This
will be one of many steps the Company is taking to make a strong
push in the $50 billion global market
for acne treatment.
In light of the withdrawal by Hoffmann-La Roche Inc. from
further manufacturing and distribution of Accutane® (isotretinoin),
the leading treatment for severe acne that is presently a subject
of a class action suit, Herborium's AcnEase is perfectly
positioned for an exponential growth as it is the all-botanical
ingredients based, safe and effective alternative for addressing
the acne problems that affect close to 60 million individuals in
the US.
Dr. Agnes P. Olszewski, Chairmen
and CEO of Herborium noted, "A social media strategy is a very cost
effective marketing tool and will allow Herborium to take advantage
of the strong consumer trends to pursue natural health alternatives
and self medication decisions. The use of social media to educate
consumers and healthcare providers about the benefits of
AcnEase is an important step in the Company's growth
strategy. This key marketing strategy for brand building will be
applied to other Herborium products; including our unique all
herbal ingredients based Women and Men Sexual Therapeutics."
"Since acne is both a disease and a social affliction,
AcnEase bridges the healthcare and personal care (beauty)
market making it an ideal candidate for a strategy using a social
media platform and will serve as an effective tool to increase both
our sales and market share," concluded Dr. Olszewski.
About AcnEase (www.acnease.com)
AcnEase® is a proprietary, all herbal, systemically acting
botanical therapeutic® targeting the symptoms of acne in both
females and males of all ages. Unlike many herbal products, AcnEase
has been validated through clinical testing. The results
demonstrated that approximately 95% of the patients with adolescent
acne responded positively to AcnEase. In adults with hormonal or
chronic acne the level of effectiveness was 85%. The overall
positive response rate to AcnEase was 91%. To date, after 5 plus
years on the market, Herborium has registered a 95.5% consumer
satisfaction rate for the AcnEase product.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company business model focuses on emerging
market opportunities spearheaded by the growth of a new market
sector located between high-cost, high-risk, ethical
pharmaceuticals and commoditized classic nutraceuticals
(supplements). The Company uses clinical validation and a
proactive regulatory strategy based on the FDA Guidance for
Industry: Botanical Drug Products (FDA Guidance 2004) to establish
and maintain a differential advantage. The company secured a
pipeline of botanical ingredients based products in the areas of
Dermatology, Prostate Health (BPH), Liver Diseases and Women's and
Men's Health and selected sexual disorders. Herborium Group sells
its products in the United States,
the United Kingdom, and
continental Europe through a
network of distributors, specialty retailers, and e-commerce.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner.
Comments are based on current management expectations, and
are considered "forward-looking statements,"
generally preceded by words such as "plans," "expects," "believes,"
"anticipates," or "intends." We cannot promise
future returns. Our statements reflect our best
judgment at the time, and we disclaim any obligation to update or
alter forward-looking statements as the result of new information
or future events. The Company urges investors
to review the risks and uncertainties contained
within its filings with the OTC Markets and/or
Securities and Exchange Commission
For more information please inquire:
DrAgnes@Herborium.com
SOURCE AcnEase
